These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 32236239)
41. Red-Blood-Cell-Membrane-Coated Metal-Drug Nanoparticles for Enhanced Chemotherapy. Liang S; Wang M; Wang J; Chen G Chembiochem; 2021 Nov; 22(22):3184-3189. PubMed ID: 34468067 [TBL] [Abstract][Full Text] [Related]
42. Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer. Cheng X; Li D; Sun M; He L; Zheng Y; Wang X; Tang R Colloids Surf B Biointerfaces; 2019 Sep; 181():185-197. PubMed ID: 31132609 [TBL] [Abstract][Full Text] [Related]
43. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity. Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289 [TBL] [Abstract][Full Text] [Related]
44. Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy. Tong F; Ye Y; Chen B; Gao J; Liu L; Ou J; van Hest JCM; Liu S; Peng F; Tu Y ACS Appl Mater Interfaces; 2020 Aug; 12(31):34630-34642. PubMed ID: 32635715 [TBL] [Abstract][Full Text] [Related]
45. Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice. Jin Q; Zhou X; Niu X; Ping C; Dong X; Duan D; Wang R; Chen Y; Pan F; Yang F; Yang X; Zhang G; Wang R; Zhang S; Ren G Colloids Surf B Biointerfaces; 2024 Sep; 241():113992. PubMed ID: 38833960 [TBL] [Abstract][Full Text] [Related]
46. CaCO Li H; Zhang X; Lin X; Zhuang S; Wu Y; Liu Z; Rong J; Zhao J J Mater Chem B; 2020 Feb; 8(6):1223-1234. PubMed ID: 31950968 [TBL] [Abstract][Full Text] [Related]
47. Multi-stimuli-responsive nanomicelles fabricated using synthetic polymer polylysine conjugates for tumor microenvironment dependent drug delivery. Augustine R; Kim DK; Kalva N; Eom KH; Kim JH; Kim I J Mater Chem B; 2020 Jul; 8(26):5745-5755. PubMed ID: 32519736 [TBL] [Abstract][Full Text] [Related]
48. DOX-Conjugated keratin nanoparticles for pH-Sensitive drug delivery. Liu P; Wu Q; Li Y; Li P; Yuan J; Meng X; Xiao Y Colloids Surf B Biointerfaces; 2019 Sep; 181():1012-1018. PubMed ID: 31382328 [TBL] [Abstract][Full Text] [Related]
49. Mesoporous silica templated-albumin nanoparticles with high doxorubicin payload for drug delivery assessed with a 3-D tumor cell model. Ménard M; Meyer F; Parkhomenko K; Leuvrey C; Francius G; Bégin-Colin S; Mertz D Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):332-341. PubMed ID: 30391506 [TBL] [Abstract][Full Text] [Related]
50. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery. Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750 [TBL] [Abstract][Full Text] [Related]
51. pH/Reduction Dual-Triggered Degradable Poly(doxorubicin) Prodrug Nanoparticles for Leakage-Free Tumor-Specific Self-Delivery. Li J; Liu P Macromol Rapid Commun; 2018 Sep; 39(18):e1800381. PubMed ID: 30073742 [TBL] [Abstract][Full Text] [Related]
53. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
54. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor. Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778 [TBL] [Abstract][Full Text] [Related]
55. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related]
56. Platelet membrane-coated nanoparticles for targeted drug delivery and local chemo-photothermal therapy of orthotopic hepatocellular carcinoma. Wu L; Xie W; Zan HM; Liu Z; Wang G; Wang Y; Liu W; Dong W J Mater Chem B; 2020 Jun; 8(21):4648-4659. PubMed ID: 32373904 [TBL] [Abstract][Full Text] [Related]
57. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
58. Dual-Sensitive Charge-Conversional Polymeric Prodrug for Efficient Codelivery of Demethylcantharidin and Doxorubicin. Wu Y; Zhou D; Zhang Q; Xie Z; Chen X; Jing X; Huang Y Biomacromolecules; 2016 Aug; 17(8):2650-61. PubMed ID: 27384255 [TBL] [Abstract][Full Text] [Related]
59. Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors. Zhao DH; Li CQ; Hou XL; Xie XT; Zhang B; Wu GY; Jin F; Zhao YD; Liu B ACS Appl Mater Interfaces; 2021 Dec; 13(47):55780-55789. PubMed ID: 34787410 [TBL] [Abstract][Full Text] [Related]
60. pH-sensitive small molecule nanodrug self-assembled from amphiphilic vitamin B6-E analogue conjugate for targeted synergistic cancer therapy. Yan G; Chen R; Xiong N; Song J; Wang X; Tang R Colloids Surf B Biointerfaces; 2020 Jul; 191():111000. PubMed ID: 32247946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]